The role of partnership in the pharmaceutical industry is ever increasing in realising the business goals. Our presentation provides a partnering scorecard for the year 2018. It also provides a pipeline gap analysis which is one of the key drivers for partnerships in pharmaceutical industry. The presentation also benchmarks the top 20 companies with respect to its current pipeline and yester year’s partnership behavior and alignment of the two with company’s growth and strategy. Furthermore, do check why we say that a typical pharmaceutical drug company will take avatar of an outcomes management company.
Richa Agrawal
Richa leads the biosimilar practice at RAS. Having followed the evolution of biosimilar industry in last five years, she has acquired relevant understanding of this space which she like to share in her posts.